FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia ...Middle East

The FDA has approved a 6-month injection form of the long-acting atypical antipsychotic paliperidone palmitate (Invega Hafyera) for adults with schizophrenia. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia )

Also on site :

• ‘A Space for All of Us’ — How Cuban Culture Comes Alive in ‘Buena Vista Social Club’ (Exclusive)
• Spain hosts European, Arab nations to pressure Israel on Gaza
• Taylor Swift and Travis Kelce break cover after being spotted on date night close to $20 million love bunker